Resonant Extends Licensing Agreement with Tier-1 Chinese Foundry Partner
Prepaid Royalty Deal Refines Partnership with Existing Tier-1 Foundry Demonstrating Mutual Commitment to Servicing Rapidly Growing Mobile Handset MarketAUSTIN, Texas,...
Month: April 2021
Tricida Announces Multiple Data Presentations to Be Given at the Virtual National Kidney Foundation 2021 Spring Clinical Meetings
SOUTH SAN FRANCISCO, Calif., April 05, 2021 (GLOBE NEWSWIRE) -- Tricida, Inc. (Nasdaq: TCDA), a pharmaceutical company focused on the development...
Golden Leaf Holdings Announces Final Closing of Non-Brokered Private Placement
NOT FOR RELEASE IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. WIRE SERVICES PORTLAND, Ore., April 05, 2021 (GLOBE...
Chinook Therapeutics Announces Update on Non-Renal Legacy Programs from Aduro Biotech Merger
Van Herk Investments to Form and Invest in Sairopa, a New Company Focused on Research and Development of B-Select Monoclonal...
Predictmedix and JUICEWORKS Form Strategic Partnership with CONNECTUS Global to Deploy Safe Entry Stations Nationwide
TORONTO, April 05, 2021 (GLOBE NEWSWIRE) -- Predictmedix Inc. (CSE:PMED) (OTCQB:PMEDF) ("Predictmedix" or the "Company") is pleased to announce a...
Selecta Biosciences to Participate at the 20th Annual Needham Healthcare Conference
WATERTOWN, Mass., April 05, 2021 (GLOBE NEWSWIRE) -- Selecta Biosciences, Inc. (NASDAQ: SELB), a biotechnology company leveraging its clinically validated...
Inari Medical Announces First Patient Enrolled in FLAME Study
IRVINE, Calif., April 05, 2021 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a commercial-stage medical device company focused...
Sensei Biotherapeutics Appoints Jessie M. English, Ph.D. to its Board of Directors
Entrepreneurial leader brings expertise growing biotech platform companiesBOSTON and ROCKVILLE, Md., April 05, 2021 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc....
Vir Biotechnology Announces New Preclinical Research Demonstrating VIR-7831 Maintains Neutralizing Activity Against the SARS-CoV-2 California Variant
– Data add to growing body of pre-clinical evidence demonstrating that VIR-7831 maintains activity against all known circulating variants of...
Teneobio Announces Achievement of Milestone Payment as Janssen Advances Phase I Study of Bispecific JNJ-75348780 for the Treatment of NHL and CLL
NEWARK, Calif., April 05, 2021 (GLOBE NEWSWIRE) -- Teneobio, Inc., a clinical stage biotech company focused on the discovery and...
Gracell Biotechnologies to Present at the 20th Annual Needham Virtual Healthcare Conference
SUZHOU, China and SHANGHAI, China, April 05, 2021 (GLOBE NEWSWIRE) -- Gracell Biotechnologies Inc. (NASDAQ: GRCL) (“Gracell”), a global clinical-stage...
Acutus Medical Initiates First IDE Therapy Trial with the AcQBlate® FORCE Sensing Ablation System
AcQBlate FORCE Sensing Ablation System A complete ablation system which includes the smallest footprint of any RF Generator and is...
Vincerx Pharma Announces Redemption of Public Warrants
PALO ALTO, Calif., April 05, 2021 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (Nasdaq: VINC) (the “Company”), today announced that it...
Pliant Therapeutics to Participate in Annual Needham Virtual Healthcare Conference
SOUTH SAN FRANCISCO, Calif., April 05, 2021 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX), a clinical stage biotechnology company...
AEON Biopharma Doses First Patient in Phase 2 Trial of ABP-450 for the Treatment of Cervical Dystonia
-Topline data expected in early-2022-NEWPORT BEACH, Calif., April 05, 2021 (GLOBE NEWSWIRE) -- AEON Biopharma, Inc., a private clinical-stage biopharmaceutical...
89bio Announces Plans for Phase 2b (ENLIVEN) Trial in NASH
- Received written guidance from FDA related to trial design and agreement to use liquid formulation -- ENLIVEN trial to...
CymaBay Appoints Thomas Wiggans and Janet Dorling to Board of Directors
NEWARK, Calif., April 05, 2021 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a clinical-stage biopharmaceutical company focused on developing...
Revo Health selects Allscripts® Practice Management
Management services organization partners with Allscripts to offer robust financial and scheduling platform to its clinics CHICAGO--(BUSINESS WIRE)--Allscripts Healthcare, LLC...
Concerns about alcohol-based sanitisers are changing the way hospitals invest in protecting their staff
MANCHESTER, UK, April 04, 2021 (GLOBE NEWSWIRE) -- As concern around the health risks of alcohol-based sanitiser grows, more hospitals...
Termination of the business combination with Second Sight Medical Products, Inc.
Termination of the business combination with Second Sight Medical Products, Inc. Paris, France, April 3, 2021 – Considering the private...